Advertisement

Index by author

April 01, 2002; Volume 301,Issue 1

  1. Walker, Christoph

    1. Pharmacological Profile of a Novel Phosphodiesterase 4 Inhibitor, 4-(8-Benzo[1,2,5]oxadiazol-5-yl-[1,7]naphthyridin-6-yl)-benzoic Acid (NVP-ABE171), a 1,7-Naphthyridine Derivative, with Anti-Inflammatory Activities
      Alexandre Trifilieff, Daniel Wyss, Christoph Walker, Lazzaro Mazzoni and Rene Hersperger
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 241-248; DOI: https://doi.org/10.1124/jpet.301.1.241

  2. Wallace, David R.

    1. Characterization of μ, κ, and δ Opioid Binding in Amphibian Whole Brain Tissue Homogenates
      Leslie C. Newman, Steven S. Sands, David R. Wallace and Craig W. Stevens
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 364-370; DOI: https://doi.org/10.1124/jpet.301.1.364

  3. Watanabe, Norihiko

    1. New Cytokine Delivery System Using Gelatin Microspheres Containing Interleukin-10 for Experimental Inflammatory Bowel Disease
      Hiroshi Nakase, Kazuichi Okazaki, Yasuhiko Tabata, Makoto Ozeki, Norihiko Watanabe, Masaya Ohana, Suguru Uose, Kazushige Uchida, Toshiki Nishi, Minoru Mastuura, Hiroyuki Tamaki, Toshiyuki Itoh, Chiharu Kawanami and Tsutomu Chiba
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 59-65; DOI: https://doi.org/10.1124/jpet.301.1.59

  4. Watkins, Paul B.

    1. Identification of a Novel Route of Extraction of Sirolimus in Human Small Intestine: Roles of Metabolism and Secretion
      Mary F. Paine, Louis Y. Leung, H. K. Lim, Kecheng Liao, Aram Oganesian, Mei-Yi Zhang, Kenneth E. Thummel and Paul B. Watkins
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 174-186; DOI: https://doi.org/10.1124/jpet.301.1.174

  5. Watts, P.

    1. Intranasal Delivery of Morphine
      L. Illum, P. Watts, A. N. Fisher, M. Hinchcliffe, H. Norbury, I. Jabbal-Gill, R. Nankervis and S. S. Davis
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 391-400; DOI: https://doi.org/10.1124/jpet.301.1.391

  6. Webster, Leslie T.

    1. Kinetic Interactions of Dopamine and Dobutamine with Human Catechol-O-methyltransferase and Monoamine Oxidase in Vitro
      Maohe Yan, Leslie T. Webster and Jeffrey L. Blumer
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 315-321; DOI: https://doi.org/10.1124/jpet.301.1.315

  7. Werling, Linda L.

    1. ς2-Receptor Regulation of Dopamine Transporter via Activation of Protein Kinase C
      Alicia E. Derbez, Rupal M. Mody and Linda L. Werling
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 306-314; DOI: https://doi.org/10.1124/jpet.301.1.306

  8. Willette, Robert N.

    1. Sustained Activation of p38 Mitogen-Activated Protein Kinase Contributes to the Vascular Response to Injury
      Haisong Ju, Sandhya Nerurkar, Charles F. Sauermelch, Alan R. Olzinski, Rosanna Mirabile, Dawn Zimmerman, John C. Lee, Jerry Adams, Joseph Sisko, Marinella Berova and Robert N. Willette
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 15-20; DOI: https://doi.org/10.1124/jpet.301.1.15

  9. Wyss, Daniel

    1. Pharmacological Profile of a Novel Phosphodiesterase 4 Inhibitor, 4-(8-Benzo[1,2,5]oxadiazol-5-yl-[1,7]naphthyridin-6-yl)-benzoic Acid (NVP-ABE171), a 1,7-Naphthyridine Derivative, with Anti-Inflammatory Activities
      Alexandre Trifilieff, Daniel Wyss, Christoph Walker, Lazzaro Mazzoni and Rene Hersperger
      Journal of Pharmacology and Experimental Therapeutics April 2002, 301 (1) 241-248; DOI: https://doi.org/10.1124/jpet.301.1.241
Back to top

In this issue

Advertisement